Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

561 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of empirical treatment recommendations from 2017 European guidelines for nosocomial pneumonia.
Calabretta D, Cilloniz C, Gabarrus A, Motos A, Galli F, Ferrer M, Fernandez-Barat L, Palomeque A, Mistraletti G, Panigada M, Pitart C, Espasa M, Martin-Loeches I, Torres A. Calabretta D, et al. Among authors: martin loeches i. Chest. 2024 Oct 24:S0012-3692(24)05398-4. doi: 10.1016/j.chest.2024.10.021. Online ahead of print. Chest. 2024. PMID: 39461555 No abstract available.
A Machine Learning Approach to Determine Risk Factors for Respiratory Bacterial/Fungal Coinfection in Critically Ill Patients with Influenza and SARS-CoV-2 Infection: A Spanish Perspective.
Rodríguez A, Gómez J, Martín-Loeches I, Claverias L, Díaz E, Zaragoza R, Borges-Sa M, Gómez-Bertomeu F, Franquet Á, Trefler S, González Garzón C, Cortés L, Alés F, Sancho S, Solé-Violán J, Estella Á, Berrueta J, García-Martínez A, Suberviola B, Guardiola JJ, Bodí M; GETGAG/COVID-19 SEMICYUC Working Group. Rodríguez A, et al. Among authors: martin loeches i. Antibiotics (Basel). 2024 Oct 14;13(10):968. doi: 10.3390/antibiotics13100968. Antibiotics (Basel). 2024. PMID: 39452234 Free PMC article.
Environmental sustainability in intensive care: the path forward. An ESICM Green Paper.
De Waele JJ, Hunfeld N, Baid H, Ferrer R, Iliopoulou K, Ioan AM, Leone M, Ostermann M, Scaramuzzo G, Theodorakopoulou M, Touw H, Citerio G, Derde LPG, Donadello K, Juffermans NP, Galarza L, Grasselli G, Maggiore SM, Martin-Loeches I, Alexandre J, Cecconi M, Azoulay E. De Waele JJ, et al. Among authors: martin loeches i. Intensive Care Med. 2024 Oct 8. doi: 10.1007/s00134-024-07662-7. Online ahead of print. Intensive Care Med. 2024. PMID: 39377790
The unique metabolic and lipid profiles of patients with severe COVID-19 compared to severe community-acquired pneumonia: a potential prognostic and therapeutic target.
Ibáñez-Prada ED, Guerrero JL, Bustos IG, León L, Fuentes YV, Santamaría-Torres M, Restrepo-Martínez JM, Serrano-Mayorga CC, Mendez L, Gomez-Duque S, Santacruz CA, Conway-Morris A, Martín-Loeches I, Gonzalez-Juarbe N, Cala MP, Reyes LF. Ibáñez-Prada ED, et al. Among authors: martin loeches i. Expert Rev Respir Med. 2024 Oct;18(10):815-829. doi: 10.1080/17476348.2024.2409264. Epub 2024 Sep 29. Expert Rev Respir Med. 2024. PMID: 39327745
Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 study.
Loiodice A, Bailly S, Ruckly S, Buetti N, Barbier F, Staiquly Q, Tabah A, Timsit JF; EUROBACT-2 Study Group, the European Society of Intensive Care Medicine (ESICM), the European Society of Clinical Microbiology, the Infectious Diseases (ESCMID) Study Group for Infections in Critically Ill Patients (ESGCIP) and the OUTCOMEREA Network. Loiodice A, et al. Clin Microbiol Infect. 2024 Sep 24:S1198-743X(24)00443-9. doi: 10.1016/j.cmi.2024.09.011. Online ahead of print. Clin Microbiol Infect. 2024. PMID: 39326671 Free article.
Inflammatory response to SARS-CoV 2 and other respiratory viruses.
Viñán Garcés AE, Cáceres E, Gómez JO, Martín-Loeches I, Reyes LF. Viñán Garcés AE, et al. Among authors: martin loeches i. Expert Rev Anti Infect Ther. 2024 Sep 11:1-14. doi: 10.1080/14787210.2024.2400548. Online ahead of print. Expert Rev Anti Infect Ther. 2024. PMID: 39228288 Review.
Understanding, assessing and treating immune, endothelial and haemostasis dysfunctions in bacterial sepsis.
Girardis M, David S, Ferrer R, Helms J, Juffermans NP, Martin-Loeches I, Povoa P, Russell L, Shankar-Hari M, Iba T, Coloretti I, Parchim N, Nielsen ND. Girardis M, et al. Among authors: martin loeches i. Intensive Care Med. 2024 Oct;50(10):1580-1592. doi: 10.1007/s00134-024-07586-2. Epub 2024 Sep 2. Intensive Care Med. 2024. PMID: 39222142 Review.
A Real-World Data Observational Analysis of the Impact of Liposomal Amphotericin B on Renal Function Using Machine Learning in Critically Ill Patients.
Sacanella I, Esteve-Pitarch E, Guevara-Chaux J, Berrueta J, García-Martínez A, Gómez J, Casarino C, Alés F, Canadell L, Martín-Loeches I, Grau S, Candel FJ, Bodí M, Rodríguez A. Sacanella I, et al. Among authors: martin loeches i. Antibiotics (Basel). 2024 Aug 12;13(8):760. doi: 10.3390/antibiotics13080760. Antibiotics (Basel). 2024. PMID: 39200060 Free PMC article.
Correction: Presentation, management, and outcomes of older compared to younger adults with hospital-acquired bloodstream infections in the intensive care unit: a multicenter cohort study.
Margalit I, Yahav D, Hoffman T, Tabah A, Ruckly S, Barbier F, Singer P, Timsit JF, Prendki V, Buetti N; EUROBACT-2 Study Group, the European Society of Intensive Care Medicine (ESICM), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Groups for Infections in Critically Ill Patients (ESGCIP) and Infections in the Elderly (ESGIE), and the OUTCOMEREA Network. Margalit I, et al. Infection. 2024 Aug 26. doi: 10.1007/s15010-024-02377-9. Online ahead of print. Infection. 2024. PMID: 39186219 No abstract available.
561 results